CLINICAL_TRIALS
trial_result
· 2016-05-27
Clinical Trial Update: An Open Label Dose Escalation Study Of E7080 [Phase 1]
Summary
Open-label Phase 1 dose-escalation trial of E7080 (lenvatinib) in solid tumors and lymphomas completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Solid Tumor or Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2016-05-27